HAEMONETICS ADDITIVE SOLUTION FORMULA 3 (AS-3)- citric acid monohydrate, sodium phosphate, monobasic, monohydrate, sodium chloride, adenine, anhydrous dextrose and trisodium citrate dihydrate solution
Intended for use only with automated red cell apheresis devices. See Operator’s Manual for additional Information and complete usage instructions.
Each 100 mL contains:
Citric Acid (Monohydrate), USP 0.042 g
Monobasic Sodium Phosphate (Monohydrate), USP 0.276 g
Sodium Chloride, USP 0.410 g
Adenine, USP 0.030 g
Dextrose (Anhydrous), USP 1.000 g
Sodium Citrate (Dihydrate), USP 0.588 g
containing 15 mEq of Sodium.
Not for direct Intravenous infusion. The pouch is a moisture barrier. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion.
nonpryogenic fluid path. Rx only.
Room temperature (25 degree C/77 degree F). Avoid excessive heat. Protect from freezing.
L322, Rev. E — 01 Product code 462A Haemonatics Corporation Braintree, MA 02184 USA Lot No. Exp. Date.
HAEMONETICS Additive Solution Formula 3 (AS-3) 250 mL Haemonatics Corporation Braintree, MA 02184 USA
| HAEMONETICS ADDITIVE SOLUTION FORMULA 3 (AS-3)
citric acid monohydrate, sodium phosphate, monobasic, monohydrate, sodium chloride, adenine, anhydrous dextrose, trisodium citrate dihydrate solution
|Labeler — Haemonetics Corporation (057827420)|
|Haemonetics Manufacturing Inc.||078598396||manufacture (57826-462)|
|Haemonetics Corporation||942344649||manufacture (57826-462)|
Revised: 10/2019 Haemonetics Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.